AIM: To assess the awareness of eye complications and the prevalence of retinopathy, in the first visit to eye clinic, among type 2 diabetic patients attending a tertiary medical centre in Kuala Lumpur, Malaysia. METHODS: An investigator-administered questionnaire was given to 137 patients with diabetes undergoing first time eye screening in the eye clinic. This was followed by a detailed fundus examination by a senior ophthalmologist to assess for presence of retinopathy. RESULTS: Almost 86% of respondents were aware of diabetic eye complications, especially in patients who had achieved tertiary educational level (96.3%). The majority of the patients (78.8%) were referred by their physicians and only 20.4% came on their own initiative. Many of the patients (43.8%) did not know how frequent they should go for an eye check-up and 72.3% did not know what treatments were available. Lack of understanding on diabetic eye diseases (68.6%) was the main barrier for most patients for not coming for eye screening earlier. Despite a high level of awareness, only 21.9% had recorded HbA1c level of <6.5% while 31.4% were under the erroneous assumption of having a good blood sugar control. A total of 29.2% had diabetic retinopathy in their first visit eye testing. CONCLUSION: In the present study, 29.2% of type 2 diabetic patients had retinopathy in their first time eye testing. Although the awareness of diabetic eye complications was high among first time eye screening patients, the appropriate eye care-seeking behavior was comparatively less and should be rectified to prevent the rise of this sight threatening eye disease.
AIM: To assess the awareness of eye complications and the prevalence of retinopathy, in the first visit to eye clinic, among type 2 diabeticpatients attending a tertiary medical centre in Kuala Lumpur, Malaysia. METHODS: An investigator-administered questionnaire was given to 137 patients with diabetes undergoing first time eye screening in the eye clinic. This was followed by a detailed fundus examination by a senior ophthalmologist to assess for presence of retinopathy. RESULTS: Almost 86% of respondents were aware of diabetic eye complications, especially in patients who had achieved tertiary educational level (96.3%). The majority of the patients (78.8%) were referred by their physicians and only 20.4% came on their own initiative. Many of the patients (43.8%) did not know how frequent they should go for an eye check-up and 72.3% did not know what treatments were available. Lack of understanding on diabetic eye diseases (68.6%) was the main barrier for most patients for not coming for eye screening earlier. Despite a high level of awareness, only 21.9% had recorded HbA1c level of <6.5% while 31.4% were under the erroneous assumption of having a good blood sugar control. A total of 29.2% had diabetic retinopathy in their first visit eye testing. CONCLUSION: In the present study, 29.2% of type 2 diabeticpatients had retinopathy in their first time eye testing. Although the awareness of diabetic eye complications was high among first time eye screening patients, the appropriate eye care-seeking behavior was comparatively less and should be rectified to prevent the rise of this sight threatening eye disease.
Authors: I J Constable; T A Welborn; R L Cooper; V J McCann; K M Stanton; D V Greer; G Stein; P Sebastian Journal: Trans Ophthalmol Soc U K Date: 1980-04
Authors: A E Alhejji; M A Alsultan; M A Alshareet; F A Alkhamis; M A Aljaafary; A I Alshaqaqiq; M R Nabouli; S Ibrahim Ali Journal: J Prev Med Hyg Date: 2020-04-02
Authors: Sami H Alzahrani; Marwan A Bakarman; Saleh M Alqahtani; Maha S Alqahtani; Nadeem Shafique Butt; Emad M Salawati; Ahmad Alkatheri; Ahmad Azam Malik; Khaled Saad Journal: Ther Adv Endocrinol Metab Date: 2018-03-04 Impact factor: 3.565
Authors: Rajan Shukla; Murthy V S Gudlavalleti; Souvik Bandyopadhyay; Raghupathy Anchala; Aashrai Sai Venkat Gudlavalleti; A T Jotheeswaran; Srikrishna S Ramachandra; Vivek Singh; Praveen Vashist; Komal Allagh; Hira Pant Ballabh; Clare E Gilbert Journal: Indian J Endocrinol Metab Date: 2016-04